Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 426

Results For "MED"

6585 News Found

Biocon - Generics & research grow; biosimilar stagnates - ICICI Securities
News | May 26, 2022

Biocon - Generics & research grow; biosimilar stagnates - ICICI Securities

ICICI Direct expects revenue CAGR of 35.6% over FY22-FY24E mainly due to the consolidation of Viatris business and they expect EBITDA margin expansion of 230bps and earnings CAGR of 64.8% over FY22-FY24E


Honeywell and Narayana Health partner to explore co-creation of healthcare technologies
Digitisation | May 26, 2022

Honeywell and Narayana Health partner to explore co-creation of healthcare technologies

Strategic partnership will develop a digital transformation roadmap and create opportunities for co-innovation in healthcare technologies


ASG Eye Hospitals opens unit in Dombivli, Maharashtra
Hospitals | May 26, 2022

ASG Eye Hospitals opens unit in Dombivli, Maharashtra

The new facility at Dombivli is the fifth ASG Eye Hospital in Maharashtra


Pristyn Care announces ‘CARES’ initiative
Startup | May 26, 2022

Pristyn Care announces ‘CARES’ initiative

Five patient-first principles to provide the highest standard of healthcare


Dr. Reddy's and Senores Pharmaceuticals launches Ketorolac Tromethamine tablets in the U.S. market
News | May 25, 2022

Dr. Reddy's and Senores Pharmaceuticals launches Ketorolac Tromethamine tablets in the U.S. market

The Toradol tablets, 10 mg brand and generic had U.S. sales of approximately US $ 16.8 million MAT for the most recent twelve months ending in March 2022 according to IQVIA


Borrena approval strengthens Pfizer position in China NSCLC market: GlobalData
News | May 25, 2022

Borrena approval strengthens Pfizer position in China NSCLC market: GlobalData

According to GlobalData’s ‘Pharmaceutical Intelligence Center’, the number of diagnosed prevalent cases of ALK-mutant NSCLC in China is estimated to grow at a CAGR of 5.3% from 22,725 in 2021 to 31,902 in 2029


Cipla scored highest among pharma companies in CRISIL’s Sustainability Rating 2022
Sustainability | May 25, 2022

Cipla scored highest among pharma companies in CRISIL’s Sustainability Rating 2022

By 2025, the company plans to achieve carbon and water neutrality, zero-waste to landfill, anti-microbial resistance stewardship and green chemistry


Lonza partners with Israel Biotech Fund to support biologics and small molecules development
Biotech | May 25, 2022

Lonza partners with Israel Biotech Fund to support biologics and small molecules development

The two-year agreement will grant Lonza access to IBF's prominent network and allow IBF to benefit from Lonza's manufacturing expertise and knowledge in its due diligence review of potential targets


European Commission approves Keytruda plus chemotherapy as neoadjuvant treatment for breast cancer
Drug Approval | May 25, 2022

European Commission approves Keytruda plus chemotherapy as neoadjuvant treatment for breast cancer

This Keytruda combination is the first immunotherapy option approved in the EU for high-risk early-stage TNBC


ENPICOM launches versatile display data analysis solution to accelerate antibody selection
Biotech | May 25, 2022

ENPICOM launches versatile display data analysis solution to accelerate antibody selection

The new IGX-Track App adds seamless analysis of antibody panning campaigns to the IGX Platform